We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Genetic Technologies Limited is a diagnostics & research business based in Australia. Genetic Technologies shares (GTG) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Genetic Technologies has a trailing 12-month revenue of around $120,554. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.005 - $0.014 |
|---|---|
| 50-day moving average | $0.0067 |
| 200-day moving average | $0.008 |
| Target price | $0.25 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.001 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.005
| 1 week (2021-12-02) | -16.67% |
|---|---|
| 1 month (2021-11-09) | -16.67% |
| 3 months (2021-09-09) | -37.50% |
| 6 months (2021-06-09) | -37.50% |
| 1 year (2020-12-09) | -28.57% |
|---|---|
| 2 years (2019-12-09) | 11.11% |
| 3 years (2018-12-07) | -40.48% |
| 5 years (2016-12-09) | -58.68% |
| Revenue TTM | $120,554 |
|---|---|
| Gross profit TTM | $-240,473 |
| Return on assets TTM | -27.88% |
| Return on equity TTM | -39.85% |
| Profit margin | 0% |
| Book value | 0.002 |
| Market capitalisation | $55.4 million |
TTM: trailing 12 months
We're not expecting Genetic Technologies to pay a dividend over the next 12 months.
Genetic Technologies 's shares were split on 28 December 1994.
Over the last 12 months, Genetic Technologies 's shares have ranged in value from as little as $0.005 up to $0.014. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Genetic Technologies 's is 0.8582. This would suggest that Genetic Technologies 's shares are less volatile than average (for this exchange).
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.
The emergency room is no place for the faint of heart.
We run through how you buy and trade cryptocurrencies on the Binance exchange.
The past 7 days have seen ETH iron out its recent volatility-induced losses.
The last 30-days have seen BTC register substantial losses of over 10%.
Australia's best weekend deals include 50% off at BCF, half-price ASICS shoes at Foot Locker, 80% off hot fashion at Nasty Gal.
Today's best online deals include: $130 off Philips air fryers, $250 off Apple AirPods Max, 50% off at Myer.
Here are the Christmas delivery cut-off dates for 50 major Australian retailers.
Kayo Sports, Australia's leading sports streaming platform, is offering a ridiculous deal for a short time.
Steps to owning and managing Alphabet shares from in Australia.
